SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-134567
Filing Date
2021-11-04
Accepted
2021-11-04 19:10:31
Documents
2
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2132040d1_3.html 3  
1 FORM 3 tm2132040d1_3.xml 3 1611
2 EXHIBIT 24 tm2132040d1_ex24.htm EX-24 4155
  Complete submission text file 0001104659-21-134567.txt   7531
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS INC. 1325 AVENUE OF THE AMERICAS 28TH FL NEW YORK NY 10019
Business Address
Bairu Menghisteab (Reporting) CIK: 0001891933 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36641 | Film No.: 211381722